Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.11 EX-10.11
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- Download Excel data file
- View Excel data file
Associated filings
- 14 May 21 424B3 Prospectus supplement
- 14 May 21 EFFECT Notice of effectiveness
- 13 May 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Apr 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
26 Mar 21 S-4 Registration of securities issued in business combination transactions
NAUT similar filings
- 13 May 21 Registration of securities issued in business combination transactions (amended)
- 23 Apr 21 Registration of securities issued in business combination transactions (amended)
- 7 Apr 21 Registration of securities issued in business combination transactions (amended)
- 26 Mar 21 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of Arya Sciences Acquisition Corp III of our report dated March 26, 2021 relating to the financial statements of Nautilus Biotechnology, Inc. which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
March 26, 2021